Company Profile
Anya Biopharm Inc., a pharmaceutical company, research and development of new biotech drugs, focusing on oral peptides and converting injectable drugs into oral formulations in Taiwan, the rest of Asia, and Europe.
The company is also developing ANY002 and ANY004, oral GLP1 products. Its portfolio also includes ANY003, a tnfa inhibitor, and ANY005. Additionally, it engages in the research, development, and testing business. Founded in 2016, Anya Biopharm is based in Taipei, Taiwan.